Joe T. Sharick

Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models

M. Schulte, Allie Fu, Ping Zhao et al. · Nature Medicine · 2018 · 486 citations

Medicine, Oncology, Pharmacology +6

Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation

Cheri A. Pasch, Peter F. Favreau, Alexander E. Yueh et al. · Clinical Cancer Research · 2019 · 248 citations · Full text

Medicine, Cancer Biology, Oncology +17

Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment

Joe T. Sharick, Christine M. Walsh, Carley M. Sprackling et al. · Frontiers in Oncology · 2020 · 142 citations · Full text

Medicine, Cell Biology, Oncology +17

Protein-bound NAD(P)H Lifetime is Sensitive to Multiple Fates of Glucose Carbon

Joe T. Sharick, Peter F. Favreau, Amani A. Gillette et al. · Scientific Reports · 2018 · 120 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids

Joe T. Sharick, Justin J. Jeffery, Mohammad Rezaul Karim et al. · Neoplasia · 2019 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17